Eric Hoffman on a Very Discreet Newcomer: Synthetic Biology
By Eric Hoffman,
A World of Science
| 01. 11. 2013
Synthetic biology was one of the themes discussed at the Assises du vivant, a forum organized jointly by UNESCO and the French NGO Vivagora in Paris on 30 November. Synthetic biology is still in its infancy but it has great ambitions: to create entirely new life forms. Borrowing techniques from engineering, the synthetic biologist assembles different parts (genes) to build an entirely new circuit. At the Assises du vivant, one proponent suggested that synthetic bacteria could be designed to glow whenever they detected explosives in the soil, alerting to buried anti-personnel mines. Others cited the potential for synthetic biofuels, biodegradable plastics and cancer drugs. But some participants were more circumspect. ‘Have the necessary safeguards been put in place? ‘, they asked. ‘Could existing organisms not fulfill the same role? Do we know how existing species will interact with these new life forms of our own creation? And what guarantee is there that they will function in the way we intended? We put these questions to Eric Hoffman, a science and technology policy expert with the US branch of the NGO...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...